Significant advancements in the treatment of relapsed or refractory large B-cell lymphoma are on the horizon. At the American Society of Hematology meeting, both Bristol Myers Squibb and Kite Pharma presented promising data from CAR-T programs aimed at this disease.
The share price of Arena Pharmaceuticals nearly doubled in premarket trading after pharma giant Pfizer announced the acquisition of the company and its diverse portfolio of developmental and clinical assets – including a late-stage ulcerative colitis treatment – in an all-cash deal valued at $6.7 billion.
Roche announced promising results for the company’s anti-TIGIT checkpoint inhibitor tiragolumab in PD-L1-positive metastatic non-small cell lung cancer.
A study out of the University of Gothenberg found that good control of blood sugar is important for decreasing the risk of cancer in obesity and type 2 diabetes.
A team of Yale researchers found a key to unlocking the deadly mystery of brain aneurysms in adults.
Eli Lilly forged a multi-year collaborative partnership with China-based Regor Therapeutics Group to discover and develop new therapies for metabolic disorders.
Moderna Inc. executives called on investors to wait for more data amid a sharp selloff in the company’s shares on Friday, after early data showed its mRNA-based flu vaccine was no better than already approved shots in the market.
Pfizer Inc. and BioNTech SE on December 9 announced that the U.S. Food and Drug Administration expanded the Emergency Use Authorization (EUA) of a booster dose of the Pfizer-BioNTech Covid-19 vaccine to include individuals 16 years of age and older.
Sweden-based Cyxone announced that topline results from the company’s Phase II study of rabeximod in Covid-19 patients with moderate disease failed to demonstrate a statistical significance from placebo.
Med Ad News’ 2021 Company of the Year Pfizer has led the global war against the COVID-19 pandemic with the vaccine Comirnaty in partnership with BioNTech. To find out about some of the other significant products and pipeline assets in Pfizer’s arsenal, Med Ad News talked to Mikael Dolsten, M.D., Ph.D., Chief Scientific Officer and President, Worldwide Research, Development and Medical.
